Literature DB >> 28975608

Inappropriate Prescribing in Older Hospitalized Adults: A Comparison of Medical Specialties.

Ana Carmen Dos Santos Ribeiro Simoes Juliano1, Alessandra Lamas Granero Lucchetti1, Jéssica Teixeira Santos da Silva1, Letícia Gomes Santos1, Jéssica Borges Taranto Nunes1, Guilherme Cortes Fernandes2, Giancarlo Lucchetti1.   

Abstract

OBJECTIVES: To evaluate the prevalence and number of potentially inappropriate medications (PIMs) in hospitalized older adults, comparing prescription patterns of medical specialties.
DESIGN: Retrospective cohort study.
SETTING: Tertiary general hospital. PARTICIPANTS: All older adults hospitalized from January through May 2015 (N = 1,900). MEASUREMENTS: Information on medications prescribed during the first and last days of hospitalization was collected and evaluated regarding PIMs using Beers and Screening Tool of Older People's Prescriptions (STOPP) criteria. Medical specialties (internal medicine, cardiology, gastroenterology, infectious disease, nephrology, neurology, pneumology) were compared regarding the prevalence of PIMs and the increase in the number of PIMs during hospitalization.
RESULTS: The number of individuals with PIMs increased significantly according to both criteria (62.3% to 66.6% according to Beers criteria, 43.4% to 50.0% according to STOPP criteria). The most common PIMs were sliding-scale insulin (26.9%), clonazepam (9.5%), and periciazine (6.4%) using Beers criteria and spironolactone (10.3%), acetylsalicylic acid (9.8%), and periciazine (8.7%) using STOPP criteria. Neurology, infectious disease, and pneumology had the highest numbers of PIMs, and neurology, pneumology, and cardiology had a greater increase in PIMs during hospitalization than the other specialties.
CONCLUSION: This study demonstrates the high and growing prevalence of PIMs in the hospital environment, according to Beers and STOPP criteria. Educational measures and specific pharmaceutical interventions for each specialty are needed to change this situation.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.

Entities:  

Keywords:  geriatrics; medical specialties; potentially inappropriate medications; prescription

Mesh:

Year:  2017        PMID: 28975608     DOI: 10.1111/jgs.15138

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Potentially Inappropriate Medication Use in Older Adults with Chronic Kidney Disease.

Authors:  Aysel Pehlivanlı; Aysu Selçuk; Şahin Eyüpoğlu; Şehsuvar Ertürk; Arif Tanju Özçelikay
Journal:  Turk J Pharm Sci       Date:  2022-06-27

2.  Potentially inappropriate medication use and related hospital admissions in aged care residents: The impact of dementia.

Authors:  Tesfahun C Eshetie; Greg Roberts; Tuan A Nguyen; Marianne H Gillam; Dorsa Maher; Lisa M Kalisch Ellett
Journal:  Br J Clin Pharmacol       Date:  2020-06-01       Impact factor: 4.335

3.  Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital.

Authors:  David Counter; James W T Millar; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2018-05-22       Impact factor: 4.335

4.  Association Between Potentially Inappropriate Medications and 30-Day Post-Hospital Discharge Outcomes in US Veterans.

Authors:  Heather G Allore; Danijela Gnjidic; Melissa Skanderson; Ling Han
Journal:  Ann Pharmacother       Date:  2021-07-20       Impact factor: 3.154

5.  Association between potentially inappropriate medications at discharge and unplanned readmissions among hospitalised elderly patients at a single centre in Japan: a prospective observational study.

Authors:  Junpei Komagamine; Taku Yabuki; Masaki Kobayashi
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

6.  The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.

Authors:  Miho Kaminaga; Junpei Komagamine; Shinpei Tatsumi
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.